Media and Investors Resources

Kuros Interim Results, 2024

English version

Press Release, 25 June 2024

Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft

Minutes of the AGM, 17 April 2024

German Version

Press Release, 24 April 2024

Adhoc Press Release

Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales

Press Release, 17 April 2024

Annual General Meeting of Kuros Biosciences approves all resolutions

Investor Webcast Presentation Video

13 Mar 2024